Adelaida Cueto
Internal Medicine · Miami Lakes, FLNPI 1780952762
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 169 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 27.7% of the total. Reporting peaked in 2024 at $1,709 and has fallen 51.4% since, to $830 in 2025. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $25.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$681
- Indivior Inc.$416
- Johnson & Johnson$305
- AbbVie$289
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$227
- plus $1K from 18 others
Across 3 payments — averaging $110,351 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$331K
What the payments were for
- Food & beverage$4,339100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 38 | $1,206 |
| Otsuka America Pharmaceutical, Inc. | 19 | $681 |
| Indivior Inc. | 17 | $416 |
| Johnson & Johnson | 16 | $305 |
| AbbVie(2 entities) | 20 | $289 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $227 |
| Boehringer Ingelheim | 7 | $217 |
| Alkermes, Inc. | 8 | $187 |
| Medtronic | 1 | $138 |
| AstraZeneca | 8 | $133 |
| E.r. Squibb & Sons, L.L.C. | 5 | $118 |
| Lilly USA, LLC | 3 | $56 |
| Novo Nordisk | 3 | $54 |
| Merck | 3 | $52 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Amarin Pharma, Inc. | 3 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $42 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Amgen | 1 | $23 |
| Boston Scientific | 1 | $22 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $18 |
| GSK | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,354 in reported general payments places this provider in the 90th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Miami Lakes
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.